Features
Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the pharmaceutical technology editorial team, identify the main drivers of the industry helping to produce regular, thought provoking opinion pieces on the latest issues, challenges and developments.Latest Pharmaceutical Feature
Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National...
> read more
By Category
Going with the flow: continuous manufacturing As manufacturing models embrace process analytical technology, big pharma has to reassess the way it produces drugs. Elisabeth Fischer profiles the opportunities and stumbling blocks of...
Investigator relations: Road to success for clinical trials Identifying and selecting the right investigator has a significant impact on the success or failure of a clinical trial. In the run-up to Arena International's Outsourcing in Clinical Trials...
Future oncology: The path to personalised medicine Could the genetic screening of tumour tissues push oncology into the era of personalised patient cancer treatment? Elisabeth Fischer talks to the researchers of the Stratified Cancer Programme...
Prefilled syringes: Getting to the point The many benefits of prefilled syringes are fuelling one of the medical device industry's fastest-growing markets. Chris Lo rolls up his sleeves to explore the finely-honed science...
Pharma Technology Focus - Issue 8 In this issue we look at securing supply chains and optimising...
Snapshot: Can increased collaboration between big pharma and academia counter industry issues? Faced with record low approval rates and a looming patent wall, collaborations are becoming increasingly important. Using detailed market data, this snapshot charts the shifting nature of...
Enhancing bioavailability Poor solubility can be critical for otherwise life-saving drugs, but new information could herald a welcome solution. Elly Earls speaks to John Comer of Sirius Analytical and Dr Woei Ping Cheng...
No risk, no reward - outsourcing the supply chain Although pharmaceutical companies rely heavily on contractors, the industry is still new to the world of outsourcing. Risk management strategies across parts of the pharmaceutical supply...
Take a load off: the age of cloud computing Excessive, unmanageable data may be to blame for low productivity rates in the drug industry. Sarah Blackman looks at how cloud computing can streamline this data to make information...
Taking aim with nanotechnology One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor,...
Twitter